Show simple item record

dc.contributor.authorAguilera-Correa, John Jairo
dc.contributor.authorGarcía-álvarez, Rafaela
dc.contributor.authorMediero Muñoz, Aránzazu
dc.contributor.authorEsteban Moreno, Jaime 
dc.contributor.authorVallet-Regí, María
dc.date.accessioned2023-01-12T10:45:26Z
dc.date.available2023-01-12T10:45:26Z
dc.date.issued2022-01-20
dc.identifier.citationBiology 11.2 (2022) 1-17en_US
dc.identifier.issn2079-7737es_ES
dc.identifier.urihttp://hdl.handle.net/10486/705844
dc.description.abstract(1) Background: Carbapenem-resistant Klesiella pneumoniae (CR-KP) infection rates depict an almost pre-antibiotic scenario since the pipeline for effective antibiotics against this pathogen has been almost entirely depleted. This study aims to evaluate the antibacterial effect of gold nanostars (GNS) alone or associated with some of the most widely used antibiotics for the treatment of CR-KP strains, i.e., meropenem or amikacin, on both planktonic and sessile forms. Additionally, we measured the effect of GNS on cell proliferation and biocompatibility in invertebrate in vivo models. (2) Materials and methods: GNS were made from gold seeds grown using a seeded-growth surfactant-free method assisted by silver ions and functionalized with mercapto-poly(ethylene glycol)amino by ligand exchange. The antimicrobial capacity, effect on cell proliferation, and biocom-patibility of the most effective combination was evaluated in a Galleria mellonella model. (3) Results: The minimum inhibitory concentration (MIC) and minimal bactericidal concentration (MBC) were 80 and 160 µM of GNS for all strains, respectively. The minimum biofilm inhibitory concentration (MBIC) and minimum biofilm eradication concentration (MBEC) were >320 µM of GNS for both. A synergy was found between GNS and amikacin. Larvae administered GNS plus amikacin were found to tolerate the treatment well, which prevented infection. (4) Conclusions: GNS are a promising anti-CR-KP nanomaterial.en_US
dc.description.sponsorshipThis research was funded by the European Research Council through ERC-2015-AdG694160 (VERDI) grant. AM is funded by grants from Instituto de Salud Carlos III through the “Miguel Servet” program (CP15/00053)en_US
dc.format.extent17 pag.es_ES
dc.format.mimetypeapplication/pdfen_US
dc.language.isoengen_US
dc.publisherMDPIes_ES
dc.relation.ispartofBiologyen_US
dc.rights© 2022 by the authorsen_US
dc.subject.otherAmikacinen_US
dc.subject.otherBiofilmen_US
dc.subject.otherCarbapenem-resistant K. pneumoniaeen_US
dc.subject.otherGold nanostarsen_US
dc.titleEffect of Gold Nanostars Plus Amikacin against Carbapenem-Resistant Klebsiella pneumoniae Biofilmsen_US
dc.typearticleen_US
dc.subject.ecienciaMedicinaes_ES
dc.relation.publisherversionhttps://doi.org/10.3390/biology11020162en_US
dc.identifier.doi10.3390/biology11020162es_ES
dc.identifier.publicationfirstpage1es_ES
dc.identifier.publicationissue2es_ES
dc.identifier.publicationlastpage17es_ES
dc.identifier.publicationvolume11es_ES
dc.relation.projectIDGobierno de España. CP15/00053; info:eu-repo/grantAgreement/EC/H2020/694160/EU//VERDIen_US
dc.type.versioninfo:eu-repo/semantics/publishedVersionen_US
dc.rights.ccReconocimientoes_ES
dc.rights.accessRightsopenAccessen_US
dc.facultadUAMFacultad de Medicinaes_ES
dc.institutoUAMInstituto de Investigación Sanitaria Fundación Jiménez Díaz (ISS-FJD)es_ES


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record